Dolphin Medical Services Board Meeting on Nov 14, 2026
Dolphin Medical Services Ltd has announced that its Board of Directors will convene on November 14, 2026. The primary agenda item is to consider and approve the Unaudited Standalone Financial Results for the second quarter and half-year ended September 30, 2026. Additionally, the company confirmed that the trading window for designated persons and insiders will remain closed from October 1, 2026, until 48 hours after the financial results are published, in compliance with SEBI's Prohibition of Insider Trading Regulations.
Key Highlights
- Board meeting scheduled for November 14, 2026.
- To approve Q2 FY27 unaudited standalone financial results.
- Trading window closure extended until 48 hours post-results.
- Compliance with SEBI Insider Trading Regulations.
Price Impact
More from DOLPHMED
Dolphin Medical: Trading Window Closes for Q2 FY27 Results
Dolphin Medical Services: Board Appoints New Chairman, Promoter Director
Dolphin Medical Services: Board Appoints Amarandhar Reddy Kotha as Chairman